Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
BBLG

BBLG - Bone Biologics Corp Stock Price, Fair Value and News

$1.68+0.01 (+0.60%)
Market Closed

Price Targets

BBLG Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

BBLG Price Action

Last 7 days

-2.3%

Last 30 days

11.3%

Last 90 days

-21.9%

Trailing 12 Months

-71.5%

BBLG RSI Chart

BBLG Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

BBLG Valuation

Market Cap

3.0M

Price/Earnings (Trailing)

-0.76

EV/EBITDA

1.5

Price/Free Cashflow

-0.91

MarketCap/EBT

-1.12

BBLG Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

BBLG Fundamentals

BBLG Earnings

Earnings (TTM)

-3.9M

Earnings Growth (Yr)

29.15%

Earnings Growth (Qtr)

9.96%

BBLG Profitability

Return on Equity

-65.59%

Return on Assets

-62.13%

Free Cashflow Yield

-110.41%

BBLG Investor Care

Shares Dilution (1Y)

337.24%

Diluted EPS (TTM)

-5.01

About Bone Biologics Corp

BBLG
Bone Biologics Corporation, a medical device company, focuses on bone regeneration in spinal fusion using the recombinant human protein. The company's NELL-1/DBM, an osteopromotive recombinant protein that provides target specific control over bone regeneration. It also develops NELL-1/DBM Fusion Device for use in spinal fusion procedures in skeletally mature patients with degenerative disc disease at one level from L2-S1. The company's platform technology is used in delivering enhanced outcomes in the surgical specialties of spinal, orthopedic, general orthopedic, plastic reconstruction, neurosurgery, interventional radiology, and sports medicine. It has a license agreement with the UCLA Technology Development Group to develop and commercialize NELL-1 for spinal fusion applications. Bone Biologics Corporation was founded in 2004 and is headquartered in Burlington, Massachusetts.
 CEO
 WEBSITEbonebiologics.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES2

Bone Biologics Corp Frequently Asked Questions

BBLG is the stock ticker symbol of Bone Biologics Corp. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Bone Biologics Corp is 3.02 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check BBLG's fair value in chart for subscribers.

The fair value guage provides a quick view whether BBLG is over valued or under valued. Whether Bone Biologics Corp is cheap or expensive depends on the assumptions which impact Bone Biologics Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for BBLG.